tm
Seeing Is Believing
tm
Seeing Is Believing
SAGE is currently covered by 17 analysts with an average potential upside of $25.89 (33.84%) from yesterday's end of day stock price of $20.01. Sage Therapeutics activity chart has currently 243 price targets and 269 ratings on display.
Analysts average stock forecasts to be materialized ratio is 55.39% with an average time for these price targets to be met of 172.3 days.
Highest price target for SAGE is $53, Lowest price target is $17, average price target is $35.
Most recent stock forecast was given by BRIAN ABRAHAMS from RBC on 08-Nov-2023. First documented stock forecast 12-Aug-2014.
Currently, out of the existing stock ratings of SAGE - 25 which are a Hold (47.17%), 28 which are a Buy (52.83%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
21
$0.11 (0.53%)
22
1 months ago
14/28 (50%)
$39.74 (43.74%)
142
Hold
22
$1.11 (5.31%)
80
1 months ago
5/12 (41.67%)
$15 (21.18%)
183
Hold
25
$4.11 (19.67%)
22
1 months 25 days ago
3/4 (75%)
$15.83 (31.14%)
107
Hold
24
$3.11 (14.89%)
25
3 months ago
5/10 (50%)
$13.18 (28.13%)
63
Hold
20
$-0.89 (-4.26%)
19
3 months 1 days ago
16/17 (94.12%)
$3.42 (7.81%)
81
What is SAGE (Sage Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on SAGE (Sage Therapeutics) with a proven track record?
Which analyst has the most public recommendations on SAGE (Sage Therapeutics)?
Which analyst is the currently most bullish on SAGE (Sage Therapeutics)?
Which analyst is the currently most reserved on SAGE (Sage Therapeutics)?
